Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism | PNAS
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF-kB inhibitors and activators | Abcam
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (∗) - Journal of Biological Chemistry
Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer | PLOS ONE
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
NF-κB - Wikipedia
PDF) Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies
Roles for NF-κB in nerve cell survival, plasticity, and disease | Cell Death & Differentiation
What is NF-κB pathway? | MBInfo
Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity | The Journal of Immunology
Targeting IKK and NF-κB for Therapy - ScienceDirect
Frontiers | Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
What is NF-κB pathway? | MBInfo
Can NF-B Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View
Multiple Facets of NF-κB in the Heart | Circulation Research
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients | SpringerLink
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
NF-κB in the crosshairs: Rethinking an old riddle - ScienceDirect
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
NF-kB inhibitors and activators | Abcam
